Please login to the form below

Not currently logged in
Email:
Password:

somapacitan

This page shows the latest somapacitan news and features for those working in and with pharma, biotech and healthcare.

Versartis crashes as VELOCITY trial veers off track

Versartis crashes as VELOCITY trial veers off track

candidate. It’s worth noting however that hGH behemoth Novo Nordisk also has a once-weekly candidate called somapacitan in phase III in Japan and Europe, although that project seems to

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics